Lyra Therapeutics Inc. (LYRA)
NASDAQ: LYRA
· Real-Time Price · USD
6.35
-0.15 (-2.31%)
At close: Sep 25, 2025, 3:59 PM
6.36
0.16%
After-hours: Sep 25, 2025, 04:04 PM EDT
-2.31% (1D)
| Bid | 6.32 |
| Market Cap | 10.44M |
| Revenue (ttm) | 770K |
| Net Income (ttm) | -38.84M |
| EPS (ttm) | -28.99 |
| PE Ratio (ttm) | -0.22 |
| Forward PE | -0.69 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 7.1 |
| Volume | 10,959 |
| Avg. Volume (20D) | 43,887 |
| Open | 6.51 |
| Previous Close | 6.50 |
| Day's Range | 6.34 - 6.80 |
| 52-Week Range | 3.81 - 37.50 |
| Beta | 0.17 |
| Ex-Dividend Date | n/a |
About LYRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LYRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LYRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsLyra Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-31.91%
Lyra Therapeutics shares are trading lower after t...
Unlock content with
Pro Subscription
3 months ago
+310.75%
Lyra Therapeutics shares are trading higher after the company announced its ENLIGHTEN 2 Phase 3 trial of LYR-210 met its primary endpoint.
